Fairmount Healthcare Fund L.P., Director Other, Director, 10% Owner at Viridian Therapeutics, Inc.\DE (VRDN), bought 909,000 shares at $11.00 ($10.0M) on 2021-09-21, disclosed to the SEC on 2021-09-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.